Treatment of triple negative breast cancer (TNBC): current options and future perspectives
De Laurentiis, M, Cianniello, D, Caputo, R, Stanzione, B, Arpino, G, Cinieri, S, Lorusso, V, De Placido, S
Published in Cancer treatment reviews (01.11.2010)
Published in Cancer treatment reviews (01.11.2010)
Get full text
Journal Article
EP.12B.14 Platinum-Pemetrexed Chemotherapy and Lorlatinib Combination in Advanced ALK Positive NSCLC Progressing to Lorlatinib: A Case Series
Bertoli, E., De Carlo, E., Montico, M., Del Conte, A., Stanzione, B., Bearz, A.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
EP.12H.05 Phase II Study on Platinum-Pemetrexed and Lorlatinib Combination in ALK-Positive NSCLC Extracranially Progressing on Lorlatinib
Bertoli, E., Da Carlo, E., Del Conte, A., Stanzione, B., Montico, M., Mazzoni, F., Camerini, A., Cortinovis, D., Delmonte, A., Metro, G., Pasello, G., Pelizzari, G., Tiseo, M., Battistuzzi, T., Bearz, A.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
Taxane-based adjuvant therapy for early breast cancer (EBC): A meta-analysis of the predictive effect of ER and HER2 status
De Laurentiis, M., Criscitiello, C., Giuliano, M., Giordano, A., Cianniello, D., Montanino, A., Falato, C., Caputo, R., Stanzione, B., De Placido, S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article